Ablynx’s shareholder structure, based on the most recent number of shares and transparency notifications, is as follows:

SH structure 8 July 2014

The Articles of the Association of Ablynx NV provide for shareholders notification threshold of 3%, 5% or a multiple of 5% (i.e. 10%, 15%, 20% etc) of the total number of existing voting rights.

The notification forms can be downloaded from the website of the FSMA. Completed and signed forms should be sent to investors@ablynx.com.

The table below provides an overview of transparency notifications received to date:

Date Press release Notification forms
2014/07/08 Press release of 8 July 2014 Fidelity Management Research LLC
2014/05/20 Press release of 20 May 2014 Biotech Value Fund Partners LP (BVF Partners LP) and Biotech Value Fund Inc (BVF Inc)
2014/04/30 Press release of 30 April 2014 Abingworth Management Limited and Abingworth LLP
2013/12/05 Press release of 5 December 2013 Perceptive Advisors LLP
2013/11/25 Press release of 25 November 2013 Biotech Value Fund Partners LP (BVF Partners LP) and Biotech Value Fund Inc (BVF Inc) Sofinnova Partners SAS
2013/10/30 Press release of 30 October 2013 Aviva Investors Global Services Limited
2013/10/18 Press release of 18 October 2013 Gimv NV and Biotech Fonds Vlaanderen NV
2013/10/01 Press release of 1 October 2013 Gimv NV and Biotech Fonds Vlaanderen NV
2013/09/30 Press release of 30 September 2013 Biotech Value Fund Partners LP (BVF Partners LP) and Biotech Value Fund Inc (BVF Inc)
2013/08/27 Press release of 27 August 2013 Gimv NV – Adviesbeheer Gimv Life Sciences 2004 NV and Biotech Fonds Vlaanderen NV
2013/05/08 Press release of 8 May 2013 KBC Asset Management NV
2013/04/17 Press release of 17 April 2013 KBC Asset Management NV
2013/03/08 Press release of 8 March 2013 Gimv NV – Adviesbeheer Gimv Life Sciences NV – Adviesbeheer Gimv Life Sciences 2004 NV and Biotech Fonds Vlaanderen NV Sofinnova Partners SAS
2012/12/14 Press release of 14 December 2012 Alta Partners (ACP IV, LP.)
2012/10/23 Press release of 23 October 2012 Sofinnova Partners SAS, Gilde Europe Food & Agribusiness Fund BV
2012/10/22 Press release of 22 October 2012 KBC Group NV and KBC Private Equity NV
2012/10/08 Press release of 8 October 2012 Gilde Europe Food & Agribusiness Fund BV
2012/04/24 Press release of 27 April 2012 VIB VZW
2011/12/23 Press release of 23 Dec 2011 Alta Partners (ACP IV, LP.)
2011/12/09 Press release of 9 Dec 2011 Multifund B.V., Nederlandia Investments B.V., Stichting Avivia
2011/11/29 Press release of 29 Nov 2011 Multifund B.V., Nederlandia Investments B.V.
2010/04/21 Press release of 23 April 2010 KBC Groep NV and KBC Private Equity NV
2010/03/18 Press release of 25 March 2010 Gimv NV, Adviesbeheer Gimv Life Sciences NV Adviesbeheer Gimv Life Sciences 2004 NV and Biotech Fonds Vlaanderen NV C.H.Boehringer Sohn AG & Co. KG and Boehringer Ingelheim International GmbH Multifund B.V., Nederlandia Investments B.V. and Stichting Avivia, KBC Groep NV and KBC Private Equity NV
2009/04/24 Press release of 24 April 2009 Denominator Transparancy notification
2009/09/21 Press release of 21 April 2009 KBC Asset Management NV
2008/09/01 Press release of 5 November 2008 Sofinnova Partners SAS Abingworth Management Limited and Abingworth LLP Alta California Partners IV, LP Gilde Europe Food & Agribusiness VIB VZW KBC Asset Management NV